查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
2019121

去心房颤动市场商业机会、成长要素、产业趋势分析及2026-2035年预测

Defibrillators Market Opportunity, Growth Drivers, Industry Trend Analysis, and Forecast 2026 - 2035
出版日期: | 出版商: Global Market Insights Inc. | 英文 130 Pages | 商品交期: 2-3个工作天内

价格
简介目录

预计到 2025 年，全球去心房颤动市场价值将达到 149 亿美元，并预计以 5.5% 的复合年增长率成长，到 2035 年达到 262 亿美元。

除颤器市场 - IMG1

推动市场成长的因素包括心血管疾病盛行率上升、心臟麻痹发生率增加、老年人口成长以及去心房颤动技术的不断进步。去心房颤动透过可控制的电击来恢復危及生命的心率患者的正常心律，广泛应用于医院、急诊室、公共场所，也可作为植入式设备使用。製造商在无线功能、即时病患监测、自动电击以及与紧急应变系统的整合等领域不断创新。携带式且易于使用的自动体外心臟去心房颤动(AED) 使即使是未经训练的公众也能迅速提供救助。穿戴式去心房颤动因其能够为高风险患者提供持续监测和即时干预、提高患者的行动能力和安全性，以及在植入式解决方案普及之前弥补治疗缺口而备受关注。

市场范围
开始年份 2025
预测期 2026-2035
上市时的市场规模 149亿美元
预测金额 262亿美元
复合年增长率 5.5%

预计到2025年，植入式心臟整流去颤器（ICD）市场份额将达到71.3%，这主要得益于其在治疗危及生命的心律失常方面的广泛临床应用、医生的大力支持以及室性心动过速和室颤病例的增加。 ICD对于长期心臟管理至关重要，因为它可以自动侦测异常心率并进行电击矫正。

预计到 2025 年，医院领域将占据 67.8% 的市场份额，达到 180 亿美元，这得益于先进去心房颤动的普及、熟练的医护人员、对复杂心臟病患者的护理以及能够进行远端监测和及时警报的数位健康技术。

预计2025年，北美去心房颤动市占率将达到37.3%，主要驱动因素包括心血管疾病高发生率、久坐的生活方式、肥胖以及相关合併症。院外心臟事件的高发生率也推动了对自动体外去颤器（AED）和植入式心臟復律去颤器（ICD）的需求。该地区汇集了许多主要的去心房颤动在全部区域普及和应用。

目录

第一章：调查方法

  • 研究途径
  • 品质改进计划
    • GMI人工智慧政策和资料完整性倡议
      • 资讯来源一致性协议
  • 调查过程和可靠性评分
    • 调查过程的组成部分
    • 评分组成部分
  • 数据收集
    • 主要来源部分列表
  • 资料探勘资讯来源
    • 付费资讯来源
      • 区域资讯来源
  • 基本估算和计算方法
    • 每种方法中基准年的计算
  • 预测模型
    • 量化市场影响分析
      • 生长参数对预测的数学影响
  • 关于调查透明度的补充信息
    • 资讯来源归属框架
    • 品质保证指标
    • 对信任的承诺

第二章执行摘要

第三章业界考察

  • 生态系分析
  • 影响产业的因素
    • 促进因素
      • 心血管疾病和心臟麻痹的发生率增加
      • 植入式和自动去心房颤动的技术进步
      • 意识提升对心肺復苏术 (CPR) 和自动体外心臟去心房颤动(AED) 使用的认识，并扩大相关训练计划。
      • 携带式和易于使用的AED设备的广泛应用
    • 产业潜在风险与挑战
      • 去心房颤动设备和维护高成本。
      • 产品召回与安全问题
    • 市场机会
      • 新兴市场除颤去心房颤动使用率不断提高
      • 去心房颤动的研发
  • 成长潜力分析
  • 监理情势（基于初步调查）
    • 北美洲
    • 欧洲
    • 亚太地区
  • 科技趋势
    • 当前技术趋势
    • 新兴技术
  • 还款方案（基于初步调查）
  • 未来市场趋势
  • 波特五力分析
  • PESTEL 分析
  • 客户洞察（基于初步研究）
  • Start-Ups情境（基于初步研究）
  • 投资趋势（基于初步调查）
  • 正在研发的产品（基于初步调查）
  • 指标趋势
    • 植入式心臟整流去颤器（ICD）
    • 穿戴式体外去心房颤动（WCD）
  • 价值链分析
  • 2025年价格分析（基于初步调查）
  • 人工智慧的影响及其未来前景
  • 差距分析

第四章 竞争情势

  • 介绍
  • 企业矩阵分析
  • 企业市占率分析（基于初步研究）
    • 世界
    • 北美洲
    • 欧洲
    • 亚太地区
  • 竞争定位矩阵
  • 主要市场公司的竞争分析
  • 主要进展
    • 併购
    • 伙伴关係与合作
    • 新产品发布
    • 业务拓展计划

第五章 市场估价与预测：依产品划分，2022-2035年

  • 植入式心臟整流去颤器（ICD）
    • 经静脉植入式心臟整流去颤器
      • 双腔ICD
      • 单腔植入式心律转復除颤器
    • 植入式心臟整流去颤器
  • 体外去心房颤动
    • 手动去心房颤动
    • 自动ED
      • 半自动体外心臟去心房颤动
      • 全自动体外心臟去心房颤动
    • 去心房颤动

第六章 市场估算与预测：依最终用途划分，2022-2035年

  • 医院
  • 门诊手术中心
  • 其他最终用户

第七章 市场估计与预测：依地区划分，2022-2035年

  • 北美洲
    • 我们
    • 加拿大
  • 欧洲
    • 德国
    • 英国
    • 法国
    • 西班牙
    • 义大利
    • 荷兰
  • 亚太地区
    • 中国
    • 日本
    • 印度
    • 澳洲
    • 韩国
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 阿根廷
  • 中东和非洲
    • 南非
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国

第八章：公司简介

  • Abbott
  • Amiitalia
  • Asahi KASEI
  • BIOTRONIK
  • Boston Scientific
  • BPL Medical Technologies
  • CU MEDICAL
  • MEDITECH
  • Medtronic
  • MicroPort
  • Mindray
  • NIHON KOHDEN
  • Philips
  • SCHILLER
  • Stryker
简介目录
Product Code: 5495

The Global Defibrillators Market was valued at USD 14.9 billion in 2025 and is estimated to grow at a CAGR of 5.5% to reach USD 26.2 billion by 2035.

Defibrillators Market - IMG1

The market growth is driven by the rising prevalence of cardiovascular diseases, increasing incidents of sudden cardiac arrest, an expanding geriatric population, and continuous advancements in defibrillator technology. Defibrillators deliver controlled electrical shocks to restore normal heart rhythm in life-threatening arrhythmias and are deployed in hospitals, emergency care, public locations, and implantable devices. Manufacturers are innovating with wireless-enabled devices, real-time patient monitoring, automated shock delivery, and integration with emergency response systems. Portable, user-friendly automated external defibrillators (AEDs) allow even untrained bystanders to provide timely assistance. Wearable defibrillators are gaining traction by offering continuous monitoring and immediate intervention for high-risk patients, improving mobility and safety while bridging the gap before implantable solutions.

Market Scope
Start Year2025
Forecast Year2026-2035
Start Value$14.9 Billion
Forecast Value$26.2 Billion
CAGR5.5%

The implantable cardioverter defibrillator (ICD) segment held a 71.3% share in 2025, driven by widespread clinical adoption for managing life-threatening arrhythmias, high physician preference, and rising ventricular tachycardia and fibrillation cases. ICDs automatically detect abnormal heart rhythms and deliver corrective shocks, making them essential for long-term cardiac management.

The hospitals segment accounted for 67.8% share in 2025 and is expected to reach USD 18 billion, supported by advanced defibrillator availability, skilled staff, complex cardiac patient care, and digital health technologies enabling remote monitoring and timely alerts.

North America Defibrillators Market held a 37.3% share in 2025 owing to a high incidence of cardiovascular diseases, sedentary lifestyles, obesity, and related comorbidities. The prevalence of out-of-hospital cardiac events has fueled demand for AEDs and ICDs. The region hosts leading defibrillator manufacturers that heavily invest in research, product development, and commercialization. Strategic collaborations with healthcare providers, ongoing product launches, and continuous technological upgrades enhance accessibility and adoption across the region.

Prominent players in the Global Defibrillators Market include Abbott, Amiitalia, Asahi KASEI, BIOTRONIK, Boston Scientific, BPL Medical Technologies, CU MEDICAL, MEDITECH, Medtronic, MicroPort, Mindray, NIHON KOHDEN, Philips, SCHILLER, and Stryker. Companies in the Global Defibrillators Market strengthen their position by investing in R&D for advanced, reliable, and connected devices, expanding product portfolios to include portable, wearable, and implantable solutions. They form partnerships with hospitals, emergency services, and distribution networks to improve reach and adoption. Focused marketing campaigns, clinical validation studies, and training programs for healthcare professionals reinforce product credibility. Regional expansion strategies target high-risk patient populations while maintaining compliance with local regulatory standards. Continuous innovation, cost optimization, and integration of AI-enabled monitoring and telehealth platforms enhance customer satisfaction, brand loyalty, and market foothold.

Table of Contents

Chapter 1 Research Methodology

  • 1.1 Research approach
  • 1.2 Quality commitments
    • 1.2.1 GMI AI policy & data integrity commitment
      • 1.2.1.1 Source consistency protocol
  • 1.3 Research trail & confidence scoring
    • 1.3.1 Research trail components
    • 1.3.2 Scoring components
  • 1.4 Data collection
    • 1.4.1 Partial list of primary sources
  • 1.5 Data mining sources
    • 1.5.1 Paid sources
      • 1.5.1.1 Sources, by region
  • 1.6 Base estimates and calculations
    • 1.6.1 Base year calculation for any one approach
  • 1.7 Forecast model
    • 1.7.1 Quantified market impact analysis
      • 1.7.1.1 Mathematical impact of growth parameters on forecast
  • 1.8 Research transparency addendum
    • 1.8.1 Source attribution framework
    • 1.8.2 Quality assurance metrics
    • 1.8.3 Our commitment to trust

Chapter 2 Executive Summary

  • 2.1 Industry 360° synopsis
  • 2.2 Key market trends
    • 2.2.1 Regional trends
    • 2.2.2 Product trends
    • 2.2.3 End use trends
  • 2.3 CXO perspectives: Strategic imperatives

Chapter 3 Industry Insights

  • 3.1 Industry ecosystem analysis
  • 3.2 Industry impact forces
    • 3.2.1 Growth drivers
      • 3.2.1.1 Rising prevalence of cardiovascular diseases and sudden cardiac arrest
      • 3.2.1.2 Technological advancements in implantable and automated defibrillators
      • 3.2.1.3 Increasing awareness and training programs for CPR and AED usage
      • 3.2.1.4 Growing adoption of portable and user-friendly AED devices
    • 3.2.2 Industry pitfalls and challenges
      • 3.2.2.1 High cost of defibrillator devices and maintenance
      • 3.2.2.2 Product recalls and safety concerns
    • 3.2.3 Market opportunities
      • 3.2.3.1 Expansion of defibrillator deployment in emerging markets
      • 3.2.3.2 Development of wearable cardioverter-defibrillators
  • 3.3 Growth potential analysis
  • 3.4 Regulatory landscape (Driven by primary research)
    • 3.4.1 North America
    • 3.4.2 Europe
    • 3.4.3 Asia Pacific
  • 3.5 Technology landscape
    • 3.5.1 Current technological trends
    • 3.5.2 Emerging technologies
  • 3.6 Reimbursement scenario (Driven by primary research)
  • 3.7 Future market trends
  • 3.8 Porter's analysis
  • 3.9 PESTEL analysis
  • 3.10 Customer insights (Driven by primary research)
  • 3.11 Start-up scenarios (Driven by primary research)
  • 3.12 Investment landscape (Driven by primary research)
  • 3.13 Pipeline products (Driven by primary research)
  • 3.14 Indication landscape
    • 3.14.1 Implantable cardioverter defibrillators (ICDs)
    • 3.14.2 Wearable external cardioverter defibrillators (WCDs)
  • 3.15 Value chain analysis
  • 3.16 Pricing analysis, 2025 (Driven by primary research)
  • 3.17 Impact of AI and its future assessment
  • 3.18 Gap analysis

Chapter 4 Competitive Landscape, 2025

  • 4.1 Introduction
  • 4.2 Company matrix analysis
  • 4.3 Company market share analysis (Driven by primary research)
    • 4.3.1 Global
    • 4.3.2 North America
    • 4.3.3 Europe
    • 4.3.4 Asia Pacific
  • 4.4 Competitive positioning matrix
  • 4.5 Competitive analysis of major market players
  • 4.6 Key developments
    • 4.6.1 Mergers & acquisitions
    • 4.6.2 Partnerships & collaborations
    • 4.6.3 New product launches
    • 4.6.4 Expansion plans

Chapter 5 Market Estimates and Forecast, By Product, 2022 - 2035 ($ Mn)

  • 5.1 Key trends
  • 5.2 Implantable cardioverter defibrillator (ICD)
    • 5.2.1 Transvenous implantable cardioverter defibrillator
      • 5.2.1.1 Dual-chamber ICDs
      • 5.2.1.2 Single-chamber ICDs
    • 5.2.2 Subcutaneous implantable cardioverter defibrillator
  • 5.3 External cardioverter defibrillator
    • 5.3.1 Manual ED
    • 5.3.2 Automated ED
      • 5.3.2.1 Semi-automated external defibrillator
      • 5.3.2.2 Fully automated external defibrillator
    • 5.3.3 Wearable cardioverter defibrillator

Chapter 6 Market Estimates and Forecast, By End Use, 2022 - 2035 ($ Mn)

  • 6.1 Key trends
  • 6.2 Hospitals
  • 6.3 Ambulatory surgical centers
  • 6.4 Other end users

Chapter 7 Market Estimates and Forecast, By Region, 2022 - 2035 ($ Mn)

  • 7.1 Key trends
  • 7.2 North America
    • 7.2.1 U.S.
    • 7.2.2 Canada
  • 7.3 Europe
    • 7.3.1 Germany
    • 7.3.2 UK
    • 7.3.3 France
    • 7.3.4 Spain
    • 7.3.5 Italy
    • 7.3.6 Netherlands
  • 7.4 Asia Pacific
    • 7.4.1 China
    • 7.4.2 Japan
    • 7.4.3 India
    • 7.4.4 Australia
    • 7.4.5 South Korea
  • 7.5 Latin America
    • 7.5.1 Brazil
    • 7.5.2 Mexico
    • 7.5.3 Argentina
  • 7.6 Middle East and Africa
    • 7.6.1 South Africa
    • 7.6.2 Saudi Arabia
    • 7.6.3 UAE

Chapter 8 Company Profiles

  • 8.1 Abbott
  • 8.2 Amiitalia
  • 8.3 Asahi KASEI
  • 8.4 BIOTRONIK
  • 8.5 Boston Scientific
  • 8.6 BPL Medical Technologies
  • 8.7 CU MEDICAL
  • 8.8 MEDITECH
  • 8.9 Medtronic
  • 8.10 MicroPort
  • 8.11 Mindray
  • 8.12 NIHON KOHDEN
  • 8.13 Philips
  • 8.14 SCHILLER
  • 8.15 Stryker